A study done on gemcitabine resistance in pancreatic cancer noted that curcumin down-regulates the expression of EZH2, PVT1 and their down-stream targets in gemcitabine-resistant cells (55). This evidence concerns the gene PVT1 and pancreatic neoplasm.